Literature DB >> 24669873

Interaction between prion protein and Aβ amyloid fibrils revisited.

Krzysztof Nieznanski1, Krystyna Surewicz, Shugui Chen, Hanna Nieznanska, Witold K Surewicz.   

Abstract

Recent studies indicate that the pathogenesis of Alzheimer disease may be related to the interaction between prion protein (PrP) and certain oligomeric species of Aβ peptide. However, the mechanism of this interaction remains unclear and controversial. Here we provide direct experimental evidence that, in addition to previously demonstrated binding to Aβ oligomers, PrP also interacts with mature Aβ fibrils. However, contrary to the recent claim that PrP causes fragmentation of Aβ fibrils into oligomeric species, no evidence for such a disassembly could be detected in the present study. In contrast, our data indicate that the addition of PrP to preformed Aβ fibrils results in a lateral association of individual fibrils into larger bundles. These findings have potentially important implications for understanding the mechanism by which PrP might impact Aβ toxicity as well as for the emerging efforts to use PrP-derived compounds as inhibitors of Aβ-induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24669873      PMCID: PMC4030797          DOI: 10.1021/cn500019c

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  26 in total

Review 1.  Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

Authors:  W L Klein; G A Krafft; C E Finch
Journal:  Trends Neurosci       Date:  2001-04       Impact factor: 13.837

2.  Membrane environment alters the conformational structure of the recombinant human prion protein.

Authors:  M Morillas; W Swietnicki; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

Review 3.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

4.  Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.

Authors:  Wataru Kudo; Hyun-Pil Lee; Wen-Quan Zou; Xinglong Wang; George Perry; Xiongwei Zhu; Mark A Smith; Robert B Petersen; Hyoung-gon Lee
Journal:  Hum Mol Genet       Date:  2011-11-18       Impact factor: 6.150

5.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.

Authors:  Darragh B Freir; Andrew J Nicoll; Igor Klyubin; Silvia Panico; Jessica M Mc Donald; Emmanuel Risse; Emmanuel A Asante; Mark A Farrow; Richard B Sessions; Helen R Saibil; Anthony R Clarke; Michael J Rowan; Dominic M Walsh; John Collinge
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

6.  The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.

Authors:  Nadine D Younan; Claire J Sarell; Paul Davies; David R Brown; John H Viles
Journal:  FASEB J       Date:  2013-01-18       Impact factor: 5.191

7.  Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity.

Authors:  Krzysztof Nieznanski; Jin-Kyu Choi; Shugui Chen; Krystyna Surewicz; Witold K Surewicz
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

8.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

9.  An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo.

Authors:  Brian R Fluharty; Emiliano Biasini; Matteo Stravalaci; Alessandra Sclip; Luisa Diomede; Claudia Balducci; Pietro La Vitola; Massimo Messa; Laura Colombo; Gianluigi Forloni; Tiziana Borsello; Marco Gobbi; David A Harris
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

10.  Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity.

Authors:  Andrew J Nicoll; Silvia Panico; Darragh B Freir; Daniel Wright; Cassandra Terry; Emmanuel Risse; Caroline E Herron; Tiernan O'Malley; Jonathan D F Wadsworth; Mark A Farrow; Dominic M Walsh; Helen R Saibil; John Collinge
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  8 in total

1.  Expression of the Prion Protein Family Member Shadoo Causes Drug Hypersensitivity That Is Diminished by the Coexpression of the Wild Type Prion Protein.

Authors:  Antal Nyeste; Petra Bencsura; István Vida; Zoltán Hegyi; László Homolya; Elfrieda Fodor; Ervin Welker
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

2.  Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.

Authors:  Jonah J Scott-McKean; Krystyna Surewicz; Jin-Kyu Choi; Vernon A Ruffin; Ahlam I Salameh; Krzysztof Nieznanski; Alberto C S Costa; Witold K Surewicz
Journal:  Neurobiol Dis       Date:  2016-03-03       Impact factor: 5.996

3.  Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer's disease.

Authors:  Nadine D Younan; Ko-Fan Chen; Ruth-Sarah Rose; Damian C Crowther; John H Viles
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

4.  Alzheimer's disease progression characterized by alterations in the molecular profiles and biogenesis of brain extracellular vesicles.

Authors:  Xavier Gallart-Palau; Xue Guo; Aida Serra; Siu Kwan Sze
Journal:  Alzheimers Res Ther       Date:  2020-05-08       Impact factor: 6.982

Review 5.  The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain.

Authors:  Rosalina Gavín; Laia Lidón; Isidre Ferrer; José Antonio Del Río
Journal:  Cells       Date:  2020-03-02       Impact factor: 6.600

6.  Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers.

Authors:  Ladan Amin; David A Harris
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919

7.  PrP (58-93) peptide from unstructured N-terminal domain of human prion protein forms amyloid-like fibrillar structures in the presence of Zn2+ ions.

Authors:  Maciej Gielnik; Zuzanna Pietralik; Igor Zhukov; Aneta Szymańska; Wojciech M Kwiatek; Maciej Kozak
Journal:  RSC Adv       Date:  2019-07-17       Impact factor: 4.036

8.  Extracellular Prion Protein Aggregates in Nine Gerstmann-Sträussler-Scheinker Syndrome Subjects with Mutation P102L: A Micromorphological Study and Comparison with Literature Data.

Authors:  Nikol Jankovska; Radoslav Matej; Tomas Olejar
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.